proline and Anemia

proline has been researched along with Anemia in 52 studies

Research

Studies (52)

TimeframeStudies, this research(%)All Research%
pre-19906 (11.54)18.7374
1990's0 (0.00)18.2507
2000's3 (5.77)29.6817
2010's42 (80.77)24.3611
2020's1 (1.92)2.80

Authors

AuthorsStudies
Berg, T; Boeker, KHW; Buggisch, P; C-Registry, GH; Günther, R; Hinrichsen, H; Klinker, H; Manns, MP; Mauss, S; Müller, T; Serfert, Y; Wiegand, J; Zeuzem, S1
Andersen, ES; Bukh, J; Christensen, PB; Fahnøe, U; Gerstoft, J; Kjær, MS; Laursen, AL; Mössner, B; Pedersen, MS; Røge, BT; Schønning, K; Sølund, C; Weis, N1
Arias, M; Belmar, L; González, LN; Laguno, M; Llovet, LP; Londoño, MC; Maduell, F; Mallolas, J; Martínez-Rebollar, M; Ojeda, R; Rodas, L; Rossi, F; Ugalde, J1
Afify, S; Alboraie, M; Algaber, MA; Doss, W; El Halwagy, H; El Kassas, M; El Latif, YA; El Tahan, A; Elsaeed, K; Elserafy, M; Omar, H1
Backus, LI; Belperio, PS; Cheung, RC; Hwang, EW; Mole, LA; Thomas, IC1
Aguilera, V; Berenguer, M; Vinaixa, C1
Afdhal, NH; Albrecht, JK; Alves, K; Bacon, BR; Balart, L; Brass, CA; Brown, RS; Burroughs, MH; Calleja, JL; Craxi, A; Deng, W; Dutko, FJ; Flamm, SL; Hézode, C; Koury, KJ; Kowdley, KV; Lawitz, E; Lee, SS; Morgan, TR; Nelson, DR; Nyberg, L; Pedicone, LD; Poordad, F; Reddy, KR; Rossaro, L; Sulkowski, MS; Wahl, J; Wedemeyer, H; Zeuzem, S1
Pol, S1
Hézode, C2
Calleja Hernández, MÁ; Fernández-López, C; García Collado, C; Jiménez Morales, A; López-Sepúlveda, R; Valencia Soto, C1
Backus, LI; Belperio, PS; Mole, LA; Neuhauser, MM; Ross, D1
Butt, AA; Freiberg, MS; Justice, AC; Lo Re, V; Shaikh, OS; Sherman, KE; Yan, P1
Bennis, Y; Bodeau, S; Brochot, E; Capron, D; Duverlie, G; Nguyen-Khac, E; Solas, C1
Broad, D; Browett, P; Donald, T; Ghallyan, N; Johnson, S; Van de Water, N1
Arends, JE; Dabis, F; Fontaine, H; Gilbert, C; Lacombe, K; Loko, MA; Miailhes, P; Puoti, M; Rockstroh, JK; Rosenthal, E; Salmon, D; Sogni, P; Winnock, M; Wittkop, L1
Albillos, A; Hernández-Guerra, M; Luis Calleja, J; Molina, E; Planas, R; Romero-Gómez, M; Turnes, J1
Ampuero, J; Andrade, RJ; Buti, M; Cabezas, J; Calleja, JL; Crespo, J; Del Campo, JA; Fernández, I; Forns, X; Lens, S; Millán, R; Rojas, L; Romero-Gómez, M1
Alberti, A; De Franceschi, L; Dissegna, D; Donato, F; Fattovich, G; Ieluzzi, D; Iolascon, A; Lupo, F; Matté, A; Piovesan, S; Raffetti, E; Russo, R; Siciliano, A; Toniutto, P; Turrini, F; Zuliani, V1
Kalsekar, A; Le, TK; Macaulay, D; Sorg, RA; Wei, J; Wu, EQ; Yuan, Y1
Cheli, S; Clementi, E; Falvella, FS; Landonio, S; Lombardi, A; Magni, C; Mazzali, C; Mondelli, MU; Rizzardini, G1
Burger, DM; Buti, M; de Kanter, CT; DeMasi, R; Dofferhoff, AS; Drenth, JP; Ouwerkerk-Mahadevan, S; Witek, J; Zeuzem, S1
Agostini, H; Alric, L; Antonini, TM; Botta-Fridlund, D; Calmus, Y; Coilly, A; De Ledinghen, V; Debette-Gratien, M; Duclos-Vallée, JC; Dumortier, J; Durand, F; Duvoux, C; Giostra, E; Guillaud, O; Latournerie, M; Lebray, P; Leroy, V; Moreno, C; Pageaux, GP; Radenne, S; Roche, B; Samuel, D; Saouli, AC1
Asselah, T; Baum, P; Böcher, WO; Bourlière, M; Bronowicki, JP; Buti, M; Gallivan, JP; Gane, EJ; Lohse, AW; Mensa, FJ; Müllhaupt, B; Roberts, SK; Schuchmann, M; Soriano, V; Stern, JO; Voss, F; Zeuzem, S1
Abel, L; About, F; Albert, ML; Bronowicki, JP; Cagnot, C; Carrat, F; Cobat, A; Duffy, D; Fontaine, H; Hézode, C; Larrey, D; Marcellin, P; Niay, J; Oudot-Mellakh, T; Pedergnana, V; Pol, S; Rabiéga, P; Sultanik, P; Theodorou, I; Zoulim, F1
Barrail-Tran, A; Bellissant, E; Bourlière, M; Cotte, L; Fournier, I; Garraffo, R; Kheloufi, F; Lacarelle, B; Molina, JM; Poizot-Martin, I; Quaranta, S; Renault, A; Solas, C1
Goncales, ES; Goncales, FL; Lazarini, MS; Mendes, LC; Miotto, N; Pedro, MN; Stucchi, RS; Vigani, AG; Zanaga, LP1
Anthony, DD; Bonomo, RA; Chandar, AK; Compan, A; Davitkov, P; Falck-Ytter, Y; Gideon, C; Hirsch, A; Silveira, MG; Smith, S1
Douna, V; Kanavakis, E; Metaxotou-Mavrommati, A; Papassotiriou, I; Stamoulakatou, A; Traeger-Synodinos, J1
Fogelberg, K; Giordano, PC; Harteveld, CL; Kaufmann, JO; Kouwenberg, J; van Zwieten, R; Verhoeven, AJ; Vuil, H1
Brennan, SO; Chan, T; Ruskova, A; Ryken, S1
Albrecht, JK; Bacon, BR; Boparai, N; Brass, CA; Bronowicki, JP; Bruno, S; DiNubile, MJ; Goodman, ZD; Jacobson, IM; Manns, MP; McCone, J; Poordad, F; Reddy, KR; Sniukiene, V; Sulkowski, MS1
Albrecht, JK; Bacon, BR; Boparai, N; Brass, CA; Burroughs, M; Esteban, R; Goodman, ZD; Gordon, SC; Lawitz, E; Marcellin, P; Poordad, F; Sings, HL; Vierling, JM; Zeuzem, S1
Jensen, DM1
Cabrera, R; Draganov, PV; Limaye, AR1
Buti, M; Homs, M1
Calle Serrano, B; Cornberg, M; Manns, MP; Markova, AA1
Forestier, N; Zeuzem, S1
Bacon, BR; Khalid, O1
Esteban, R; Shiffman, ML1
Reinke, T1
Casey, LC; Lee, WM1
Afdhal, NH; Albrecht, JK; Brass, CA; Bronowicki, JP; Burroughs, MH; Harrison, SA; Jacobson, IM; Koury, KJ; Manns, MP; Pedicone, LD; Poordad, F; Rajender Reddy, K; Sings, HL; Sniukiene, V; Sulkowski, MS1
Kwo, PY1
Heil, EL; Hynicka, LM1
Braun, B; Klaus, D; Lederle, RM1
Fujimi, S; Hirakata, H; Iseki, K; Kumagai, H; Omae, T; Onoyama, K1
Charnock, DR; Isseroff, H; Spengler, RN1
Algermissen, B; Hampl, H; Nündel, M; Riedel, E; Scigalla, P; Stabell, U1
Baum, BJ; Faris, B; Franzblau, C; Grasso, JA; Kagan, HM; Troxler, RF1
Manis, J1

Reviews

12 review(s) available for proline and Anemia

ArticleYear
[Progress in hepatitis C treatment].
    Medicina clinica, 2013, Nov-16, Volume: 141, Issue:10

    Topics: Anemia; Antiviral Agents; Clinical Trials, Phase III as Topic; Drug Eruptions; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Transplantation; Multicenter Studies as Topic; Oligopeptides; Polyethylene Glycols; Proline; Protease Inhibitors; Pruritus; Randomized Controlled Trials as Topic; Recurrence; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load; Viremia

2013
Management of anaemia and other treatment complications.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2013, Sep-30, Volume: 45 Suppl 5

    Topics: Anemia; Antiviral Agents; Contraindications; Drug Eruptions; Drug Therapy, Combination; Dysgeusia; Hemorrhoids; Hepatitis C, Chronic; Humans; Interferons; Oligopeptides; Patient Selection; Platelet Count; Polyethylene Glycols; Proline; Pruritus Ani; Ribavirin; Serum Albumin

2013
[Triple therapy in cirrhotic patients and those with advanced fibrosis: relevant aspects in clinical practice].
    Gastroenterologia y hepatologia, 2014, Volume: 37 Suppl 1

    Topics: Anemia; Antiviral Agents; Clinical Trials as Topic; Cohort Studies; Comorbidity; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Hypertension, Portal; Interferon-alpha; Liver Cirrhosis; Medication Adherence; Metabolic Syndrome; Oligopeptides; Polyethylene Glycols; Proline; Protease Inhibitors; Ribavirin; Risk Factors

2014
[New agents for the treatment of hepatitis C].
    Enfermedades infecciosas y microbiologia clinica, 2012, Volume: 30, Issue:3

    Topics: Anemia; Antiviral Agents; Clinical Trials, Phase III as Topic; Drug Discovery; Drug Eruptions; Drugs, Investigational; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Molecular Targeted Therapy; Multicenter Studies as Topic; Oligopeptides; Polyethylene Glycols; Proline; Protease Inhibitors; Recombinant Proteins; Ribavirin; Spain; Viral Nonstructural Proteins

2012
Phase III results of Boceprevir in treatment naïve patients with chronic hepatitis C genotype 1.
    Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32 Suppl 1

    Topics: Anemia; Antiviral Agents; Clinical Trials, Phase III as Topic; Drug Delivery Systems; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Polyethylene Glycols; Proline; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; RNA, Viral; Serine Proteinase Inhibitors; Treatment Outcome

2012
Boceprevir and telaprevir for the treatment of chronic hepatitis C: safety management in clinical practice.
    Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32 Suppl 1

    Topics: Anemia; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-alpha; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors; Skin Diseases; Withholding Treatment

2012
Triple therapy with telaprevir: results in hepatitis C virus-genotype 1 infected relapsers and non-responders.
    Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32 Suppl 1

    Topics: Adult; Aged; Anemia; Antiviral Agents; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Recurrence; Ribavirin; Serine Proteinase Inhibitors; Skin Diseases; Treatment Failure; Treatment Outcome; Virus Replication; Young Adult

2012
Triple therapy with boceprevir for HCV genotype 1 infection: phase III results in relapsers and nonresponders.
    Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32 Suppl 1

    Topics: Anemia; Antiviral Agents; Clinical Trials, Phase III as Topic; Drug Substitution; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-alpha; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Recurrence; Ribavirin; Serine Proteinase Inhibitors; Skin Diseases; Standard of Care; Treatment Failure

2012
Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?
    Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32 Suppl 1

    Topics: Algorithms; Anemia; Antiviral Agents; Clinical Protocols; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Drug Therapy, Combination; Genotype; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferons; Interleukins; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors; Skin Diseases; Time Factors; Viral Load

2012
Hepatitis C therapy update.
    Current opinion in gastroenterology, 2012, Volume: 28, Issue:3

    Topics: Anemia; Antiviral Agents; Drug Therapy, Combination; Genotype; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Risk Factors

2012
Boceprevir and treatment of chronic hepatitis C.
    Clinics in liver disease, 2013, Volume: 17, Issue:1

    Topics: Anemia; Antiviral Agents; Coinfection; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors

2013
Anemia management in patients with chronic viral hepatitis C.
    The Annals of pharmacotherapy, 2013, Volume: 47, Issue:2

    Topics: Anemia; Antiviral Agents; Drug Monitoring; Drug Therapy, Combination; Erythropoietin; Hematinics; Hepacivirus; Hepatitis C, Chronic; Humans; Oligopeptides; Proline; Ribavirin; Risk Factors; Serine Proteinase Inhibitors; Viral Nonstructural Proteins

2013

Trials

7 trial(s) available for proline and Anemia

ArticleYear
Outcome and adverse events in patients with chronic hepatitis C treated with direct-acting antivirals: a clinical randomized study.
    European journal of gastroenterology & hepatology, 2018, Volume: 30, Issue:10

    Topics: 2-Naphthylamine; Adult; Anemia; Anilides; Antiviral Agents; Benzimidazoles; Carbamates; Cyclopropanes; Drug Therapy, Combination; Fatigue; Female; Fluorenes; Genotype; Headache; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Ribavirin; Ritonavir; Sofosbuvir; Sulfonamides; Treatment Outcome; Uracil; Valine; Viral Load

2018
Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial.
    Gastroenterology, 2013, Volume: 145, Issue:5

    Topics: Algorithms; Anemia; Antiviral Agents; Disease Management; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythropoietin; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Logistic Models; Male; Middle Aged; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Treatment Outcome

2013
ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection.
    PloS one, 2015, Volume: 10, Issue:12

    Topics: Acrylates; Aminoisobutyric Acids; Anemia; Antiviral Agents; Benzimidazoles; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Interferons; Leucine; Male; Middle Aged; Oligopeptides; Polymorphism, Single Nucleotide; Proline; Pyrophosphatases; Quinolines; Real-Time Polymerase Chain Reaction; Ribavirin; Thiazoles

2015
Treatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis C.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Anemia; Antiviral Agents; Cost-Benefit Analysis; Drug Therapy, Combination; Drug Tolerance; Female; Hepatitis C; Hospitalization; Humans; Interferon-alpha; Male; Middle Aged; Mood Disorders; Oligopeptides; Proline; Ribavirin; Severity of Illness Index; Treatment Outcome

2016
Boceprevir for untreated chronic HCV genotype 1 infection.
    The New England journal of medicine, 2011, Mar-31, Volume: 364, Issue:13

    Topics: Adult; Anemia; Antiviral Agents; Black People; Double-Blind Method; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; RNA, Viral; Serine Proteinase Inhibitors; Treatment Outcome; Viral Load

2011
Boceprevir for previously treated chronic HCV genotype 1 infection.
    The New England journal of medicine, 2011, Mar-31, Volume: 364, Issue:13

    Topics: Anemia; Antiviral Agents; Double-Blind Method; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Logistic Models; Male; Middle Aged; Polyethylene Glycols; Proline; Recombinant Proteins; Retreatment; Ribavirin; RNA, Viral; Serine Proteinase Inhibitors; Treatment Outcome; Viral Load

2011
Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial.
    Hepatology (Baltimore, Md.), 2013, Volume: 57, Issue:3

    Topics: Adult; Anemia; Antiviral Agents; Drug Therapy, Combination; Erythropoietin; Female; Hematinics; Hemoglobins; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Placebos; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors; Treatment Outcome

2013

Other Studies

33 other study(ies) available for proline and Anemia

ArticleYear
Hepatitis C therapy with direct antiviral agents in patients with advanced chronic kidney disease: real-world experience of the German Hepatitis C-Registry (Deutsches Hepatitis C-Register).
    European journal of gastroenterology & hepatology, 2019, Volume: 31, Issue:11

    Topics: 2-Naphthylamine; Acute Disease; Adult; Aged; Anemia; Anilides; Antiviral Agents; Benzimidazoles; Carbamates; Cyclopropanes; Disease Progression; Drug Therapy, Combination; Female; Fluorenes; Germany; Glomerular Filtration Rate; Hepatitis C, Chronic; Humans; Hypertension; Imidazoles; Lactams, Macrocyclic; Liver Cirrhosis; Macrocyclic Compounds; Male; Middle Aged; Pleural Effusion; Proline; Pyrrolidines; Registries; Renal Insufficiency, Chronic; Ribavirin; Ritonavir; RNA, Viral; Severity of Illness Index; Simeprevir; Sofosbuvir; Sulfonamides; Sustained Virologic Response; Treatment Outcome; Uracil; Uridine Monophosphate; Valine

2019
Elimination of hepatitis C virus infection from a hemodialysis unit and impact of treatment on the control of anemia.
    Gastroenterologia y hepatologia, 2019, Volume: 42, Issue:3

    Topics: 2-Naphthylamine; Anemia; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Darbepoetin alfa; Female; Hematinics; Hematocrit; Hemoglobin A; Hepatitis C; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Ritonavir; Sulfonamides; Sustained Virologic Response; Uracil; Valine

2019
High success rates for the use of ombitasvir/paritaprevir/ritonavir containing regimens in treatment of naïve and experienced chronic hepatitis C genotype 4: Real world results.
    Journal of medical virology, 2022, Volume: 94, Issue:2

    Topics: Adult; Anemia; Anilides; Antiviral Agents; Cyclopropanes; Drug Therapy, Combination; Fatigue; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Liver Cirrhosis; Male; Middle Aged; Proline; Prospective Studies; Ribavirin; Ritonavir; Sofosbuvir; Sulfonamides; Sustained Virologic Response; Valine

2022
Early virologic responses and hematologic safety of direct-acting antiviral therapies in veterans with chronic hepatitis C.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2013, Volume: 11, Issue:8

    Topics: Aged; Anemia; Antiviral Agents; Drug-Related Side Effects and Adverse Reactions; Female; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Oligopeptides; Proline; Prospective Studies; Ribavirin; Treatment Outcome; Veterans; Viral Load

2013
HCV, ribavirin, and anemia: a new dawn.
    Gastroenterology, 2013, Volume: 145, Issue:5

    Topics: Anemia; Erythropoietin; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin

2013
[Boceprevir and telaprevir safety in routine clinical practice].
    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2014, Jan-01, Volume: 38, Issue:1

    Topics: Adult; Aged; Anemia; Antiviral Agents; Female; Humans; Male; Middle Aged; Oligopeptides; Proline; Rectal Diseases; Retrospective Studies; Thrombocytopenia

2014
A population approach to disease management: hepatitis C direct-acting antiviral use in a large health care system.
    Journal of managed care & specialty pharmacy, 2014, Volume: 20, Issue:6

    Topics: Anemia; Antiviral Agents; Biomarkers; Comparative Effectiveness Research; Delivery of Health Care; Drug Prescriptions; Drug Therapy, Combination; Education, Medical, Continuing; Education, Pharmacy, Continuing; Guideline Adherence; Hematinics; Hepacivirus; Hepatitis C; Humans; Medication Therapy Management; Oligopeptides; Pharmaceutical Services; Practice Guidelines as Topic; Practice Patterns, Physicians'; Proline; Registries; RNA, Viral; Time Factors; Treatment Outcome; United States; United States Department of Veterans Affairs; Viral Load

2014
Virologic response and haematologic toxicity of boceprevir- and telaprevir-containing regimens in actual clinical settings.
    Journal of viral hepatitis, 2015, Volume: 22, Issue:9

    Topics: Aged; Anemia; Antiviral Agents; Cohort Studies; Drug-Related Side Effects and Adverse Reactions; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Neutropenia; Oligopeptides; Proline; RNA, Viral; Thrombocytopenia; Treatment Outcome; Viral Load

2015
Patients treated with first-generation HCV protease inhibitors exhibit high ribavirin concentrations.
    Journal of clinical pharmacology, 2015, Volume: 55, Issue:5

    Topics: Adult; Aged; Anemia; Antiviral Agents; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hemoglobins; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Proline; Protease Inhibitors; Recombinant Proteins; Retrospective Studies; Ribavirin

2015
Hb Feilding [β12(A9)Thr → Pro; HBB: c.37A>C]: a novel unstable β-globin chain variant.
    Hemoglobin, 2015, Volume: 39, Issue:1

    Topics: Aged; Anemia; Base Sequence; beta-Globins; Female; Hemoglobins, Abnormal; Humans; Models, Molecular; Mutation, Missense; Proline; Protein Structure, Secondary; Threonine

2015
Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients.
    Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:9

    Topics: Anemia; Antiviral Agents; Cohort Studies; Coinfection; Drug Therapy, Combination; Female; France; Genotype; Germany; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Italy; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Oligopeptides; Proline; Ribavirin; RNA, Viral; Treatment Outcome

2015
Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2015, Volume: 68

    Topics: Adolescent; Adult; Aged; Anemia; Antiviral Agents; Drug Therapy, Combination; Female; Genetic Predisposition to Disease; Hepatitis C, Chronic; Humans; Incidence; Male; Membrane Transport Proteins; Middle Aged; Oligopeptides; Proline; Prospective Studies; Protease Inhibitors; Pyrophosphatases; Ribavirin; Risk Assessment; Young Adult

2015
Protease inhibitors-based therapy induces acquired spherocytic-like anaemia and ineffective erythropoiesis in chronic hepatitis C virus patients.
    Liver international : official journal of the International Association for the Study of the Liver, 2016, Volume: 36, Issue:1

    Topics: Adult; Aged; Anemia; Antiviral Agents; Drug Monitoring; Drug Therapy, Combination; Erythrocyte Indices; Erythrocyte Membrane; Erythropoiesis; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Oligopeptides; Polymorphism, Single Nucleotide; Proline; Protease Inhibitors; Pyrophosphatases; Ribavirin; Treatment Outcome

2016
Costs and Resource Utilization Associated With Anemia and Rash in Chronic Hepatitis C Patients Treated With Direct-Acting Antiviral Agents in the United States.
    Clinical therapeutics, 2015, Volume: 37, Issue:8

    Topics: Adult; Aged; Anemia; Antiviral Agents; Databases, Factual; Drug Costs; Drug Eruptions; Drug Therapy, Combination; Female; Health Care Costs; Health Resources; Hepatitis C, Chronic; Humans; Male; Middle Aged; Oligopeptides; Proline; Ribavirin; United States

2015
ITPA and SLC29A1 Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors.
    Pharmacology, 2015, Volume: 96, Issue:3-4

    Topics: Adult; Aged; Anemia; Antiviral Agents; Drug Therapy, Combination; Equilibrative Nucleoside Transporter 1; Female; Genotype; Hemoglobins; Hepacivirus; Hepatitis C; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Proline; Protease Inhibitors; Pyrophosphatases; Ribavirin

2015
Ribavirin concentration determines treatment success of first-generation DAA-based chronic HCV therapy.
    Antiviral therapy, 2016, Volume: 21, Issue:2

    Topics: Anemia; Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Oligopeptides; Proline; Ribavirin

2016
Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?
    PloS one, 2015, Volume: 10, Issue:9

    Topics: Adult; Aged; Anemia; Antiviral Agents; Combined Modality Therapy; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Host-Pathogen Interactions; Humans; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Oligopeptides; Polyethylene Glycols; Postoperative Period; Proline; Prospective Studies; Protease Inhibitors; Recombinant Proteins; Recurrence; Thrombocytopenia; Treatment Outcome

2015
Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study.
    PloS one, 2015, Volume: 10, Issue:12

    Topics: Anemia; beta 2-Glycoprotein I; Drug Therapy, Combination; Hemoglobins; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Interleukins; Liver Cirrhosis; Oligopeptides; Polymorphism, Single Nucleotide; Proline; Pyrophosphatases; Treatment Outcome

2015
Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy.
    AIDS (London, England), 2016, 08-24, Volume: 30, Issue:13

    Topics: Anemia; Antiviral Agents; Coinfection; Decision Support Techniques; Drug Therapy, Combination; Female; Genotyping Techniques; Glomerular Filtration Rate; Hepatitis C, Chronic; HIV Infections; Humans; Male; Membrane Transport Proteins; Oligopeptides; Pharmacogenomic Testing; Polymorphism, Single Nucleotide; Proline; Ribavirin

2016
Predictors of early treatment discontinuation and severe anemia in a Brazilian cohort of hepatitis C patients treated with first-generation protease inhibitors.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2016, Jun-23, Volume: 49, Issue:7

    Topics: Adult; Aged; Anemia; Antiviral Agents; Female; Glomerular Filtration Rate; Hepatitis C, Chronic; Humans; Interferon-alpha; Logistic Models; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Proline; Prospective Studies; Protease Inhibitors; Recombinant Proteins; Ribavirin; Risk Factors; Severity of Illness Index; Statistics, Nonparametric; Sustained Virologic Response; Time Factors; Treatment Failure; Young Adult

2016
Association of mild and severely unstable alpha chain variants: the first observation of a compound heterozygote with Hb Setif [alpha94(G1)Asp-->Tyr (alpha2)] and Hb Agrinio [alpha29(B10)Leu-->Pro (alpha2)] in a Greek family.
    Hemoglobin, 2008, Volume: 32, Issue:6

    Topics: Adult; alpha-Globins; Amino Acid Substitution; Anemia; Aspartic Acid; Child; Child, Preschool; Female; Greece; Hemoglobins, Abnormal; Heterozygote; Humans; Leucine; Male; Middle Aged; Proline; Tyrosine

2008
Hb Nile[A1] and Hb Nile[A2]: novel identical [alpha77(EF6)Pro-->Ser] variants found in either the alpha1- or alpha2-globin genes.
    Hemoglobin, 2009, Volume: 33, Issue:3

    Topics: alpha-Globins; Anemia; Child; Chromatography, High Pressure Liquid; Codon; Electrophoresis, Capillary; Female; Hemoglobins, Abnormal; Humans; Isoelectric Focusing; Male; Mutation, Missense; Pregnancy; Proline; Serine; Young Adult

2009
A second case of Hb Fontainebleau [alpha21(B2)Ala-->Pro] in an individual with microcytosis.
    Hemoglobin, 2009, Volume: 33, Issue:3

    Topics: Adult; Alanine; Amino Acid Substitution; Anemia; Erythrocyte Indices; Hemoglobins, Abnormal; Humans; Male; Proline; Spectrometry, Mass, Electrospray Ionization

2009
A new era of hepatitis C therapy begins.
    The New England journal of medicine, 2011, Mar-31, Volume: 364, Issue:13

    Topics: Anemia; Antiviral Agents; Black People; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors

2011
Boceprevir for chronic HCV genotype 1 infection.
    The New England journal of medicine, 2011, 07-14, Volume: 365, Issue:2

    Topics: Anemia; Antiviral Agents; Drug Therapy, Combination; Erythropoietin; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors; Viral Load

2011
FDA Advisory Committee reviews safety of boceprevir.
    AIDS patient care and STDs, 2011, Volume: 25, Issue:6

    Topics: Anemia; Bone Marrow; Hepatitis C; Humans; Proline; Protease Inhibitors; United States; United States Food and Drug Administration

2011
New hepatitis C regimen stimulates changes in therapy management.
    Managed care (Langhorne, Pa.), 2011, Volume: 20, Issue:12

    Topics: Anemia; Antiviral Agents; Disease Management; Drug Interactions; Hematinics; Hepatitis C; Humans; Oligopeptides; Proline; Protease Inhibitors; Standard of Care

2011
[Captopril in the treatment of essential hypertension (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1980, Sep-19, Volume: 105, Issue:38

    Topics: Adult; Aldosterone; Anemia; Captopril; Humans; Hypertension; Middle Aged; Peptidyl-Dipeptidase A; Potassium; Proline; Propranolol; Renin

1980
Worsening of anemia induced by long-term use of captopril in hemodialysis patients.
    American journal of nephrology, 1984, Volume: 4, Issue:6

    Topics: Adult; Aged; Anabolic Agents; Anemia; Body Weight; Captopril; Humans; Hypertension; Male; Middle Aged; Proline; Renal Dialysis; Time Factors

1984
Fascioliasis: similarities of the anemia in rats to that produced by infused proline.
    The Journal of parasitology, 1979, Volume: 65, Issue:5

    Topics: Amino Acids; Anemia; Animals; Erythrocyte Count; Erythrocyte Indices; Fasciola hepatica; Fascioliasis; Proline; Rats

1979
Changes in the concentrations of hydroxyproline, glycine and serine in the plasma of haemodialysis patients undergoing erythropoietin therapy.
    Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie, 1989, Volume: 27, Issue:11

    Topics: Adult; Aged; Anemia; Erythropoietin; Female; Follow-Up Studies; Glycine; Hemoglobins; Humans; Hydroxyproline; Male; Middle Aged; Parathyroid Hormone; Proline; Recombinant Proteins; Renal Dialysis; Serine

1989
Incorporation of L-azetidine-2-carboxylic acid into hemoglobin in rabbit reticulocytes.
    Biochemical and biophysical research communications, 1973, Aug-21, Volume: 53, Issue:4

    Topics: Amino Acids; Anemia; Animals; Azetines; Carbon Radioisotopes; Hemoglobins; Hydrolysis; Imino Acids; Phenylhydrazines; Proline; Rabbits; Reticulocytes; Tritium; Trypsin

1973
Intestinal iron-transport defect in the mouse with sex-linked anemia.
    The American journal of physiology, 1971, Volume: 220, Issue:1

    Topics: Anemia; Animals; Biological Transport, Active; Calcium; Diet; Duodenum; Female; Galactose; Genes, Recessive; In Vitro Techniques; Intestine, Small; Iron; Iron Isotopes; Male; Metabolism, Inborn Errors; Mice; Pregnancy; Proline; Sex Chromosomes

1971